Loading company…
Singular Genomics develops sequencing instruments and tools for genomic and multi-omics research.
Founded in 2016 and based in California, Singular Genomics develops genomic sequencing technology, including the G4 sequencer and consumable kits, as well as the PX multi-omics system. Its customers include research institutions, laboratories, and clinical settings. Deerfield Management acquired the company for USD 20 per share in a public-to-private deal in December 2024.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in